Summary

Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services such as rosetta cancer origin test, resetta lung cancer test, rosetta kidney cancer test and rosetta mesothelioma test. RGL product pipeline includes tests such as thyroid neoplasia, oncology project, kidney rejection, Alzheimer's disease, therapeutics and CMV. The company has distribution network in Australia, New Zealand, Singapore, Canada, Greece, India, Saudi Arabia, Qatar, the UAE, Israel and Turkey. The company has its presence in the UA. RGL is headquartered in Rehovot, Israel.

Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Rosetta Genomics, Ltd., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Rosetta Genomics, Ltd., Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Rosetta Genomics, Ltd., Medical Equipment, Deal Details 13
Partnerships 13
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Rosetta Genomics Enters Into Licensing Agreement With Avatao Biotech 15
Rosetta Genomics Enters into Co-Marketing Agreement with Admera Health 16
Rosetta Genomics Enters into Co-Development Agreement with Institute of Molecular Translational Medicine 17
Rosetta Genomics Enters into Co-Development Agreement with Global Pharma Company 18
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 19
Rosetta Genomics Enters Into Co-Development Agreement With Rabin Medical 20
Rosetta Genomics Expands Distribution Agreement With Genekor 21
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 22
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics 24
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 25
Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 26
Rosetta Genomics Enters Into Agreement With Tel Hashomer Medical Research, Infrastructure And Services 28
Rosetta Genomics Enters Into Agreement With Carmel Medical Center 29
Rosetta Genomics Enters Into Distribution Agreement With Genekor 30
Rosetta Genomics Enters Into An Agreement With Genetic Technologies 31
Rosetta Genomics Enters Into Distribution Agreement With Super Religare Labs 32
Warnex Signs Distribution Agreement With Rosetta Genomics 33
Teva Pharma Enters Into An Agreement With Rosetta Genomics 34
Prometheus Labs Signs An Agreement With Rosetta Genomics 35
Equity Offering 36
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To US$75 Million 36
Rosetta Genomics Completes Underwriters' Exercise Of Over-Allotment Option For US$4 Million 37
Rosetta Genomics Completes Private Placement Of Shares For US$6.6 Million 39
Rosetta Genomics Completes Private Placement Of Shares For US$2 Million 41
Rosetta Genomics Completes Private Placement Of Shares For US$1.4 Million 42
Rosetta Genomics Completes Private Placement Of Common Stock For US$1.5 Million 43
Rosetta Genomics Completes Private Placement For US$2.7 Million 45
Rosetta Genomics Completes Registered Direct Offering For US$3.3 Million 47
Rosetta Genomics Completes Private Placement For US$2.5 Million 49
Rosetta Genomics Completes Registered Direct Offering Of Shares For US$5.1 Million 51
Rosetta Genomics Completes Private Placement Of US$8 Million 53
Debt Offering 54
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For US$1.75 Million 54
Rosetta Genomics, Ltd. - Key Competitors 55
Key Employees 56
Locations And Subsidiaries 57
Head Office 57
Other Locations and Subsidiaries 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables

Rosetta Genomics, Ltd., Medical Equipment, Key Facts, 2013 1
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Rosetta Genomics, Ltd., Medical Equipment Deals By Type, 2009 to YTD 2015 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Rosetta Genomics, Ltd., Deals By Market, 2009 to YTD 2015 9
Rosetta Genomics, Ltd., Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Rosetta Genomics To Enter Into Licensing Agreement For microRNA Intellectual Property And Technology 13
Rosetta Enters Into Licensing Agreement For Patents Related To Cancer Applications 14
Rosetta Genomics Enters Into Licensing Agreement With Avatao Biotech 15
Rosetta Genomics Enters into Co-Marketing Agreement with Admera Health 16
Rosetta Genomics Enters into Co-Development Agreement with Institute of Molecular Translational Medicine 17
Rosetta Genomics Enters into Co-Development Agreement with Global Pharma Company 18
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 19
Rosetta Genomics Enters Into Co-Development Agreement With Rabin Medical 20
Rosetta Genomics Expands Distribution Agreement With Genekor 21
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 22
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics 24
Rosetta Genomics Amends Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 25
Rosetta Genomics Enters Into Co-Marketing Agreement With Precision Therapeutics For miRview mets2 Assays 26
Rosetta Genomics Enters Into Agreement With Tel Hashomer Medical Research, Infrastructure And Services 28
Rosetta Genomics Enters Into Agreement With Carmel Medical Center 29
Rosetta Genomics Enters Into Distribution Agreement With Genekor 30
Rosetta Genomics Enters Into An Agreement With Genetic Technologies 31
Rosetta Genomics Enters Into Distribution Agreement With Super Religare Labs 32
Warnex Signs Distribution Agreement With Rosetta Genomics 33
Teva Pharma Enters Into An Agreement With Rosetta Genomics 34
Prometheus Labs Signs An Agreement With Rosetta Genomics 35
Rosetta Genomics Files Shelf Registration Statement For Public Offering Of Securities For Up To US$75 Million 36
Rosetta Genomics Completes Underwriters' Exercise Of Over-Allotment Option For US$4 Million 37
Rosetta Genomics Completes Private Placement Of Shares For US$6.6 Million 39
Rosetta Genomics Completes Private Placement Of Shares For US$2 Million 41
Rosetta Genomics Completes Private Placement Of Shares For US$1.4 Million 42
Rosetta Genomics Completes Private Placement Of Common Stock For US$1.5 Million 43
Rosetta Genomics Completes Private Placement For US$2.7 Million 45
Rosetta Genomics Completes Registered Direct Offering For US$3.3 Million 47
Rosetta Genomics Completes Private Placement For US$2.5 Million 49
Rosetta Genomics Completes Registered Direct Offering Of Shares For US$5.1 Million 51
Rosetta Genomics Completes Private Placement Of US$8 Million 53
Rosetta Genomics Completes Private Placement Of Debentures Due 2013 For US$1.75 Million 54
Rosetta Genomics, Ltd., Key Competitors 55
Rosetta Genomics, Ltd., Key Employees 56
Rosetta Genomics, Ltd., Other Locations 57
Rosetta Genomics, Ltd., Subsidiaries 57

List of Figures

Rosetta Genomics, Ltd., Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Rosetta Genomics, Ltd., Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Rosetta Genomics, Ltd., Medical Equipment, Deals by Type, 2009 to YTD 2015 7
Rosetta Genomics, Ltd., Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Rosetta Genomics, Ltd., Medical Equipment, Deals by Market, 2009 to YTD 2015 9

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Rubicon Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

Rubicon Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Rubicon Genomics, Inc. (Rubicon) is a medical device company. The company develops and commercializes pre-analytical processes to improve the performance and capabilities of analytical platforms ...

Pathway Genomics Corporation - Medical Equipment - Deals and Alliances Profile

Pathway Genomics Corporation - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Pathway Genomics Corporation (Pathway Genomics) is a genetic testing laboratory. The laboratory provides physicians with genetic testing reports on diet and exercise, drug response, carrier status ...

BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary BioNano Genomics, Inc. (BioNano) is a biotechnology company. The company provides a platform to analyze the long segments of genomic DNA and other structural variations. It has developed Irys technology, ...

Genomic Health, Inc.

March 2015 $ 55

Rosetta Genomics Ltd. (usa)

March 2015 $ 55

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.